The HF-HRV Registry

NCT00236236 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2006-11-14

No results posted yet for this study

Summary

The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.

Conditions

Interventions

DEVICE

Cardiac Resynchronization Therapy

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Kellie Chase · Guidant Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Completion
2005-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00236236 on ClinicalTrials.gov